After adjustment for covariates (gender, age, cancer stage and treatment strategy), patients with higher pre-CCRT PD-L1 had shorter overall survival than those without (HR = 2.814, 95% confidence interval CI = 1.196–6.618, p = 0.018) (Table 2). Here, CD274 is linked to cancer.